Hwail Pharmaceutical Co.Ltd Capital Reinvestment Ratio
Hwail Pharmaceutical Co.Ltd capital reinvestment ratio. Hwail Pharmaceutical Co.Ltd (061250) has a Capital Reinvestment Ratio of 0.20x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.82 Billion) in capital expenditures (₩1.39 Billion). Check 061250 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hwail Pharmaceutical Co.Ltd (2011–2024)
Capital reinvestment ratio of Hwail Pharmaceutical Co.Ltd from 2011 to 2024. This chart tracks Hwail Pharmaceutical Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore 061250 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Hwail Pharmaceutical Co.Ltd Capital Reinvestment Ratio by Year (2011–2024)
Hwail Pharmaceutical Co.Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see 061250 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.98x | ₩11.63 Billion | ₩34.63 Billion | ▲ +894.9% |
| 2023 | 0.30x | ₩7.02 Billion | ₩2.10 Billion | ▲ +143.3% |
| 2021 | 0.12x | ₩20.09 Billion | ₩2.47 Billion | ▼ -58.2% |
| 2019 | 0.29x | ₩3.69 Billion | ₩1.09 Billion | ▲ +36.1% |
| 2018 | 0.22x | ₩7.17 Billion | ₩1.55 Billion | ▲ +250.9% |
| 2017 | 0.06x | ₩8.34 Billion | ₩513.62 Million | ▲ +42.9% |
| 2016 | 0.04x | ₩9.58 Billion | ₩413.00 Million | ▼ -96.7% |
| 2013 | 1.32x | ₩6.97 Billion | ₩9.18 Billion | ▼ -82.9% |
| 2012 | 7.69x | ₩1.00 Billion | ₩7.72 Billion | ▲ +1034.5% |
| 2011 | 0.68x | ₩7.86 Billion | ₩5.32 Billion | — |